United States: Enforcement Considerations For The Health Care Industry In The Wake Of The WannaCry Ransomware Attack

On May 12, 2017, the WannaCry ransomware cryptoworm attacked over 230,000 computers in over 150 countries, holding data on the computers for ransom. WannaCry spread rapidly through networked systems that had not been updated with Microsoft security patches. The attack was particularly alarming because WannaCry victims included a number of hospitals and health systems. The ransomware affected the ability of many hospitals to access patient medical records, billing records, and even data from certain medical devices linked to the hospitals' systems, in some cases interfering directly with hospitals' ability to provide patient care.

In the wake of the WannaCry attack, many organizations have asked themselves what steps they can take to guard against a future attack—and what might happen if they fail to do so. In the first part of this series,1 our colleagues addressed what Boards of Directors and senior management should ask of their companies information security and business teams in order to assess how prepared a company is to respond to and recover from a ransomware attack. In this second part of the series, we discuss potential legal ramifications that may result if organizations—especially those in the health care sector—fail to prepare for a ransomware attack. Health care companies face increasingly high expectations around data security and, as the real-world effects of cyber-attacks continue to rise, government authorities may very well take increasingly aggressive steps to ensure companies are taking concerted action to keep patient information safe.

HIPAA Compliance

In the U.S., health care providers such as hospitals (known as "covered entities") must comply with the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act and implementing regulations (collectively, "HIPAA"). HIPAA requires that covered entities and organizations that assist covered entities with certain tasks involving the use or disclosure of patient information (known as "business associates") adopt administrative, physical and technological safeguards to ensure the confidentiality, integrity and availability of patient health information known as "protected health information" or "PHI." Relevant to ransomware attacks, mandatory safeguards include requirements to "allow access [to PHI] only to those persons or software programs that have been granted access rights,"2 to "protect electronic protected health information from improper alteration or destruction,"3 and to "guard against unauthorized access to electronic protected health information that is being transmitted over an electronic communications network."4

Federal HIPAA Enforcement—Office for Civil Rights and Department of Justice

Organizations that fail to implement these mandatory safeguards in a satisfactory manner may face liability under HIPAA. The Department of Health and Human Services ("HHS") Office for Civil Rights ("OCR") is responsible for enforcing HIPAA. Covered entities and business associates that experience a "breach" of PHI (i.e., an event that compromises the privacy or security of patient information) must affirmatively report such breach to OCR and affected individuals. If there are fewer than 500 individuals affected, OCR may choose to investigate the breach; if there are more than 500 individuals affected, OCR must investigate the breach. Such investigations frequently include an examination of both the factors that may have caused the breach and the covered entity or business associate's general HIPAA compliance. OCR may review an organization's HIPAA compliance for the past six years as part of its investigation. If a covered entity or business associate is found to have violated HIPAA, OCR may impose civil monetary penalties that range from $100 to $50,000 per violation (with an annual maximum fine per violation of $1.5 million), with aggregate penalties trending higher in recent years.

For entities affected by WannaCry or other ransomware attacks, OCR has issued sub-regulatory guidance5 that indicates a ransomware attack is presumed to be a HIPAA breach unless the organization can make a fact-specific determination that there is a low probability the patient information was compromised by the attack. As we have previously explained,6 in the eyes of OCR, it may be difficult to conclude that a ransomware attack was not a breach, particularly if there is a "high risk" that the data's integrity was compromised.

In addition, the Department of Justice ("DOJ") has authority to enforce criminal HIPAA provisions prohibiting knowing disclosures of protected data. Over the last ten years, the DOJ has shown increased willingness to pursue criminal penalties for HIPAA violations.7 In 2015, for instance, four employees of pharmaceutical company Warner Chilcott were convicted of criminal HIPAA violations for reviewing patient records during visits to physicians' offices. HIPAA's criminal provisions would be directly applicable to ransomware attackers; however, enterprising prosecutors could argue that egregious conduct on the part of health care organizations–such as willful blindness to the need for data security measures–amounts to a "knowing" disclosure of patient information and warrants enforcement action. While prosecutors would face an uphill battle charging a ransomware victim with "knowing" complicity in an attack, a breach resulting in significant patient harm may trigger a correspondingly aggressive response from enforcers.8

State Attorneys General

State Attorneys General also have authority under federal and often state law to seek damages on behalf of state residents in the event of a health care-related data breach. The HITECH Act of 2009 gave State Attorneys General the power to seek injunction or damages in any instance in which he or she has "reason to believe that an interest of one or more of the residents of that State has been or is threatened or adversely affected by" exposure of PHI in violation of HIPAA.9

In addition to HIPAA, State Attorneys General often have a variety of state law remedies at their disposal to seek redress for patients harmed by a data breach at a hospital or other healthcare provider. Consumer protection statutes, for instance, may provide a cause of action where a data breach was occasioned by an unfair or deceptive act by the healthcare provider,10 and State Attorneys General may contend that failure to implement appropriate safeguards or a violation of existing policies intended to protect patient information constitutes an unfair or deceptive act. These consumer protection statutes can greatly increase a healthcare company's exposure in the event of a data breach.11 Many states also have their own data security12 or health records laws13 that may provide additional sources of enforcement authority.

The Massachusetts Attorney General's office has been particularly aggressive in exercising its HIPAA authority and pursuing state remedies when patient data is disclosed. Since 2012, Massachusetts has secured settlements in five suits resulting from data breaches at hospitals and other healthcare providers. For example, the Massachusetts Attorney General reached a $750,000 settlement with a community hospital for alleged failure to appropriately protect patient information when backup tapes containing names, Social Security numbers, and medical diagnoses for over 800,000 patients were lost during shipment to an offsite vendor. Later, medical billing company Goldthwait Associates and four pathology groups that used its services paid a total of $140,000 in settlements to the Massachusetts Attorney General when Goldthwait allegedly disposed of patient medical records in a public dump. Even though the pathology groups that contracted with Goldthwait had no active involvement in the allegedly improper disposal of patient information, they were accused of failing to appropriately vet Goldthwait as a service provider.14 Finally, the Massachusetts Attorney General settled three separate suits against Massachusetts hospitals allegedly arising out of thefts of unencrypted laptops and backup tapes containing patient information. These cases underscore the importance ensuring appropriate protection for patient information—both from inadvertent disclosure and intentional attacks—even after it leaves the healthcare provider's control or premises.

Other State Attorneys General, including those in New York and New Jersey, have shown a willingness to pursue actions under HIPAA. In 2015, New York's Attorney General sought penalties against the University of Rochester Medical Center ("URMC") under HIPAA where a nurse accessed URMC patient records and provided a list of patient names and addresses to a future employer.15 In addition, the New Jersey Attorney General recently reached a $1.1 million settlement agreement with Blue Cross/Blue Shield after the theft of unencrypted laptops compromised data from nearly 690,000 customers.16 The complaint alleged broad scale failure to implement appropriate technological controls to protect PHI and PI and failure to train and supervise employees with access to HIPAA-protected information. As data breaches become more common, health care companies should expect more State Attorneys General to embrace the HIPAA enforcement authority granted by the HITECH Act to pursue remedies where state residents are impacted.

Federal Trade Commission

The Federal Trade Commission ("FTC") has authority to bring enforcement actions against certain parties engaged in unfair or deceptive trade practices under Section 5 of the FTC Act.17 The agency has taken the position that data security failures can constitute unfair or deceptive practices under the statute, and has taken numerous enforcement actions based on that position.18 Recently, the FTC has increasingly focused these actions against healthcare companies, despite the fact that their data security practices are already regulated by OCR and State Attorneys General.19 The FTC has also focused on ransomware in the past year, providing a workshop series as well as advice to consumers and businesses on how to avoid and respond to ransomware.20 The increasing scope of the FTC's enforcement activities, as well as its recent focus on ransomware, should emphasize to healthcare organizations that enforcement in the wake of a ransomware incident may come from a number of regulatory agencies, including the FTC.

The WannaCry attack should be a wake-up call to health care organizations. This month, HHS's Health Care Industry Cybersecurity Task Force categorized health care cybersecurity as "in critical condition" and warned that the industry that health care companies must take "immediate and aggressive" action to secure IT networks and valuable patient data.21 Increased enforcement activity, high penalties for noncompliance, increasingly sophisticated hacking and ransomware attacks and warnings from Federal agencies have created a perfect enforcement storm for unprepared organizations in the health care industry.

Footnotes

1. Ropes & Gray, "Don't WannaCry: Ten Questions Boards and Company Management Can Ask in the Wake of Recent Ransomware Attacks," available at: https://www.ropesgray.com/newsroom/alerts/2017/05/Dont-WannaCry-Ten-Questions-Boards-and-Company-Management-Can-Ask-in-the-Wake.aspx.

2. 45 CFR § 164.312(a)(1).

3. 45 CFR § 164.312(c)(1).

4. 45 CFR § 164.312(e)(1).

5. HHS, "FACT SHEET: Ransomware and HIPAA," available at: https://www.hhs.gov/sites/default/files/RansomwareFactSheet.pdf.

6. Law360, "Inside The HHS Guidance On Ransomware," available at: https://www.law360.com/articles/823234/inside-the-hhs-guidance-on-ransomware.

7. See, e.g., https://archives.fbi.gov/archives/littlerock/press-releases/2009/lr102609.htm (Arkansas health care workers pleaded guilty to misdemeanor HIPAA violations for accessing patient medical records out of "curiosity."); https://www.justice.gov/archive/usao/are/news/2008/April/SmithLPNplea%20HIPAA%20041508.pdf (Arkansas nurse pleaded guilty to a felony HIPAA violation for sharing health information with her husband for use against a patient in a legal proceeding).

8. Bryan v. United States, 524 U.S. 184, 193 (1998).

9. 42 U.S. Code § 1320d–5.

10. See, e.g., M.G.L. c. 93A (Massachusetts Consumer Protection Act).

11. See, Star Tribune, "Accretive is banned from Minnesota," available at: http://www.startribune.com/accretive-banned-from-minnesota-for-at-least-2-years-to-pay-2-5m/164313776/.

12. See, e.g., M.G.L. c. 93H (Massachusetts Data Privacy Law, imposing a duty to report promptly any known or suspected data breaches and establishing the authority of the Massachusetts consumer affairs bureau to promulgate regulations regarding appropriate data security precautions for businesses).

13. See, e.g., MINN. STAT. 144.291-.298 (2016) (Minnesota Health Records Act).

14. See, http://www.mass.gov/ago/news-and-updates/press-releases/2013/140k-settlement-over-medical-info-disposed-of-at-dump.html.

15. See, https://ag.ny.gov/press-release/ag-schneiderman-announces-settlement-university-rochester-prevent-future-patient.

16. See, http://nj.gov/oag/newsreleases17/pr20170217a.html.

17. 15 U.S.C. § 45.

18. https://www.ftc.gov/enforcement/cases-proceedings/terms/249.

19. See, e.g., https://www.ftc.gov/enforcement/cases-proceedings/102-3099/labmd-inc-matter.

20. See "Ransomware – A closer look," available at: https://www.ftc.gov/news-events/blogs/business-blog/2016/11/ransomware-closer-look; and "FTC Offers Advice on How to Avoid and Respond to Ransomware Attacks," available at: https://www.ftc.gov/news-events/press-releases/2016/11/ftc-offers-advice-how-avoid-respond-ransomware-attacks.

21. See Health Care Industry Cybersecurity Task Force, "Report on Improving Cybersecurity in the Health Care Industry," available at: https://www.phe.gov/Preparedness/planning/CyberTF/Documents/report2017.pdf.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions